1. Three-year report of population based cancer registries 2009–2011, National Cancer Registry Programme (Indian Council of Medical Research), 2013. http://ncrpindia.org
2. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81.
3. Shukla VK, Gurubachan SD, et al. Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder. Trop Gastroenterol. 2006;27(160–165):2006.
4. Del Favero G, Fabris C, Panucci A, et al. Carbohydrate antigen 19–9 (CA 19–9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction. Bull Cancer. 1986;73:251–5.
5. Rana S, Dutta U, Kochhar R, et al. Evaluation of CA 242 as a tumour marker in gallbladder cancer. J Gastrointest Cancer. 2012;43(2):267–71.